Innate or natural immunity is a highly conserved defense mechanism against
infection found in all multicellular organisms. The acute phase response is
the set of immediate inflammatory responses initiated by pattern recogniti
on molecules. These germ cell-encoded proteins recognize microbial pathogen
s based on shared molecular structures and induce host responses that local
ize the spread of infection and enhance systemic resistance to infection. I
nnate immunity also influences the initiation and type of adaptive immune r
esponse by regulating T cell costimulatory activity and antigen presentatio
n by antigen presenting cells and by influencing mediator production, which
affects lymphocyte function and trafficking. Acute phase protein concentra
tions rapidly increase after infection, and their production is controlled
primarily by IL-6- and IL-l-type cytokines. The acute phase proteins provid
e enhanced protection against microorganisms and modify inflammatory respon
ses by effects on cell trafficking and mediator release. For example, serum
amyloid A has potent leukocyte activating functions including induction of
chemotaxis, enhancement of leukocyte adhesion to endothelial cells, and in
creased phagocytosis. The constellation of inflammatory responses seen afte
r endotoxin administration to humans represents an in vivo model of the acu
te phase response. Studies with inflammatory modifying agents, such as solu
ble dimeric TNF receptor and IL-10, show that these responses are not depen
dent on a single mediator but result from multiple overlapping inflammatory
pathways. Understanding the factors that initiate and alter the magnitude
and duration of the acute phase response represents an important step in th
e development of new therapies for infectious and inflammatory diseases.